Adaptor proteins and ubiquinators in TGF-beta signaling

Lopa Mishra1, Blair Marshall

  • 1Laboratory of Digestive Diseases, Department of Surgery, Medicine & Lombardi Cancer Center, Georgetown University, Washington, DC, USA. lm229@georgetown.edu

Insights

Research into the TGF-beta signaling pathway reveals its role in stem cell plasticity and cancer. Understanding key protein interactions, like ELF and PRAJA, may lead to new cancer therapeutics.

Area of Science:

  • Oncology
  • Molecular Biology
  • Stem Cell Biology

Background:

  • The Transforming Growth Factor-beta (TGF-beta) signaling pathway is crucial for stem cell plasticity and differentiation.
  • Smads, key mediators of TGF-beta signaling, are modulated by adaptor proteins (e.g., ELF, SARA) and ubiquitinators (e.g., PRAJA, SMURFs).
  • TGF-beta pathway inactivation is common in gastrointestinal tumors, but early inactivating mutations are rare, suggesting other regulatory mechanisms.

Purpose of the Study:

  • To investigate the role of stem/progenitor cell proteins, specifically ELF and PRAJA, in modulating TGF-beta signaling in cancer.
  • To identify key interactions within the TGF-beta pathway that could be targeted for cancer therapy.

Main Methods:

  • Analysis of TGF-beta signaling pathway components and their interactions.
  • Investigating the function of adaptor proteins and ubiquitinators in cancer contexts.
  • Exploring the link between stem cell proteins and TGF-beta pathway regulation.

Main Results:

  • The study highlights the significant influence of proteins like ELF and PRAJA on TGF-beta signaling.
  • Evidence suggests these proteins play a role in tumor formation where canonical TGF-beta pathway mutations are absent.
  • Key interactions involving Smads, adaptor proteins, and ubiquitinators are implicated in cancer development.

Conclusions:

  • Modulation of TGF-beta signals by stem/progenitor cell proteins like ELF and PRAJA is critical in cancers.
  • Targeting these specific protein interactions offers a promising therapeutic strategy for difficult-to-treat cancers.
  • Further research into these pathways could unlock novel treatments for gastrointestinal and other cancers.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...